Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
Condition: Allergic Conjunctivitis Interventions: Drug: Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo; Drug: Ketotifen fumarate ophthalmic solution 0.035%; Drug: Brimonidine tartrate ophthalmic solution 0.025%; Drug: Vehicle ophthalmic solution Sponsor: Bausch & Lomb Incorporated Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2022 Category: Research Source Type: clinical trials
Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.
Conditions: Chronic Conjunctivitis; Stevens-Johnson Syndrome; Lyell Syndrome; Pemphigoid Interventions: Drug: Single Dose; Drug: Double Dose Sponsors: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; Effice Servicios Para la Investigacion S.L. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2022 Category: Research Source Type: clinical trials
